Denison Mines (DML) — Stock Analysis 2026 [3.7]
Analysis as of 8 September 2026. Denison Mines stock analysis. Price deck: base uranium US$90/lb U₃O₈ — the representative trailing average of the industry month-end price, snapped to the fixed US$60–120/lb grid — with every grid price run as a scenario (deep bear US$60, bear US$75, base US$90, bull US$105, deep bull US$120) and analyst consensus as a 0% cross-check — no spot price. Share price CA$4.62 (TSX close, 8 September 2026); at that price the market implies a uranium deck of ~US$125/lb. Fair value CA$3.17, implied −31.4%. Fundamentals from the FY2025 annual filings, the Q2 2026 interim statements and MD&A (filed 12 August 2026) and the 2023 Wheeler River technical report as updated by the January 2026 capital estimate. Figures are Canadian dollars (CA$) unless marked US$. Refreshed on each annual report and on material events. Rating: ★★★½ Solid / Overvalued (wide band).
Denison Mines is building Phoenix, an in-situ recovery uranium mine in Saskatchewan’s Athabasca Basin, on a 56.7 mlb reserve grading 11.7% U₃O₈. The thesis in one line: a licensed and funded build with a study all-in cost of US$18.41/lb, held back by a ten-year mine life and a share price that already pays 2.09 times this analysis’s net asset value. Why now: the final investment decision came on 24 February 2026, more than 20% of site civil work was done by the end of July, and first production is targeted for mid-2028. To screen Denison against every listed uranium name on reserves, grade, cost and stage, use Metal Pilot’s uranium mining stock screener.
1. Snapshot & thesis
Figure 1. Denison Mines in numbers
Figure data: Denison’s Q2 2026 interim statements and MD&A and FY2025 MD&A (cash, notes, Phoenix parameters and capital, schedule); share price per Yahoo Finance DML.TO, 8 September 2026 close; NAV, fair value and read per Section 7; rating per Section 9.
Denison Mines Corp. (TSX: DML; NYSE American: DNN) is a uranium company headquartered in Toronto and working in the Athabasca Basin of northern Saskatchewan, across about 457,000 hectares. By archetype it is a developer in the uranium sector: its value sits in the 95%-owned Wheeler River project — Phoenix, under construction, and Gryphon, at pre-feasibility level — beside 22.5% of the McClean Lake joint venture and 25.17% of the Midwest joint venture (both operated by Orano), 70.55% of Waterbury Lake and 950,000 lb of physical uranium. U₃O₈ is uranium concentrate; mlb means million pounds; in-situ recovery (ISR) dissolves the uranium in place and pumps it to surface.
Table 1. Denison Mines in numbers
| Metric | Value | As of |
|---|---|---|
| Share price / market capitalisation | CA$4.62 / CA$4,182m (US$3,035m) | 8 Sep 2026 |
| Shares, basic / fully diluted / if-converted | 905.2m / 920.2m / 1,038.5m | 12 Aug 2026 |
| Phoenix reserve (100%) | 56.7 mlb at 11.7% U₃O₈ | 23 Jun 2023 |
| Probable reserves, Phoenix + Gryphon (100% / Denison) | 103.0 mlb / 97.8 mlb | 31 Dec 2025 |
| Phoenix cash cost / all-in cost (study) | CA$8.51 (US$6.28) / CA$24.92 (US$18.41) per lb | 2023 FS |
| Cash margin at the study all-in cost, US$90/lb | 79.5% | 8 Sep 2026 |
| Phoenix post-FID capital / remaining | CA$600.0m / CA$559.2m | 30 Jun 2026 |
| Cash / convertible notes at face | CA$465.3m / US$345m | 30 Jun 2026 |
| Revenue / net loss | CA$4.9m / CA$217.3m | FY2025 |
| NAV per share | CA$2.21 | 8 Sep 2026 |
| Fair value / implied return | CA$3.17 / implied −31.4% | 8 Sep 2026 |
| Quality rating / valuation read | 3.7/5 Solid / Overvalued (wide band), implied −31.4% | 8 Sep 2026 |
Source: Denison’s Q2 2026 interim statements and MD&A, FY2025 statements and MD&A and the Wheeler River technical report on SEDAR+; price per Yahoo Finance, 8 September 2026, at USD/CAD 1.3778. Cash margin = (base price − study all-in cost) ÷ base price; the Phoenix costs are feasibility-study estimates, not achieved results. Remaining capital, NAV, fair value and read per Section 7.
The thesis in brief. The bull case: Phoenix holds its provincial and federal approvals and its construction licence, cash and physical uranium cover the CA$559 million of construction capital still to spend, and a study cash cost of US$6.28/lb is a seventh of what Paladin achieved at Langer Heinrich in FY2026. The bear case: the reserve supports ten years of Phoenix output, Gryphon is unpermitted and unfunded, and the shares trade at 2.09 times NAV. What tips it is whether the Phase 1 freeze wall and the first wellfield perform to the study by mid-2028.
How to read this analysis: the statcards and Section 9 carry the verdict; Sections 2–6 hold the evidence and Section 7 the valuation.
2. Assets & operations
Every Denison asset is uranium and every one is in northern Saskatchewan; for the market behind the price deck, see the Uranium — A Complete Market Guide.
2.1 Portfolio overview
Table 2. Denison Mines asset portfolio
| Asset | Country | Stage | Interest | Output (100%) | Reserves (100%) | Life | Unit cost | Listing / operator |
|---|---|---|---|---|---|---|---|---|
| Wheeler River — Phoenix (ISR) | Canada (Saskatchewan) | Under construction; FID 24 Feb 2026 | 95% effective | 8.4 mlb/yr, years 1–5 (study) | 56.7 mlb P&P at 11.7% | 10 yr | US$18.41/lb all-in (study) | Denison (TSX: DML), operator |
| Wheeler River — Gryphon (underground) | Canada (Saskatchewan) | Pre-feasibility; unpermitted | 95% effective | 7.6 mlb/yr (study) | 49.7 mlb Probable at 1.8% | 6.5 yr | US$25.47/lb all-in (study) | Denison (TSX: DML), operator |
| Midwest JV — Midwest Main (ISR) | Canada (Saskatchewan) | Preliminary economic assessment (2025) | 25.17% | 37.4 mlb over ~6 yr (PEA) | — | ~6 yr | — | Orano (private), operator |
| McClean Lake JV — mill and SABRE | Canada (Saskatchewan) | Producing (SABRE) and toll milling | 22.5% | 145,926 lb, Denison share (2025) | — | — | ~CA$36/lb cash cost (2025) | Orano (private), operator |
| Waterbury Lake (THT, Huskie) | Canada (Saskatchewan) | Exploration and evaluation | 70.55% | — | — | — | — | Denison (TSX: DML) |
Source: Denison Q2 2026 interim statements, note 1 (interests), the FY2025 MD&A pp.3, 14–15 (Phoenix and Gryphon parameters, Midwest PEA) and the 2025 Annual Information Form (SABRE output and cost); reserves under NI 43-101, effective 23 June 2023. Study figures are estimates, not achieved results.
Concentration is the defining fact. Phoenix carries 76.5% of the enterprise net asset value in Section 7, and Gryphon — on the same property, under the same joint venture — a further 18.2%; McClean Lake and Midwest together carry 5.3%. One deposit, one province and one mining method make up the company, and revenue until Phoenix produces is a rounding error: CA$4.9 million in 2025.
2.2 Value and pounds by asset
Denison is pre-revenue, so a split of sales by metal and by asset would show one bar each. The two figures show instead where the modelled value sits and where the planned pounds sit.
Figure 2. Enterprise NAV by asset, base case
Figure data: Section 7, Table 12 — Phoenix CA$1,464.9m, Gryphon CA$348.2m, Midwest CA$66.0m, McClean Lake CA$35.5m, resource CA$1.3m. Cash, the physical uranium and the convertible notes sit in the equity bridge, not in this figure. Values are this analysis’s model, not company figures.
Figure 3. Attributable planned pounds by asset
Figure data: Phoenix 56.7 mlb and Gryphon 49.7 mlb of reserves at 95% (53.9 mlb and 47.2 mlb) and the Midwest PEA’s 37.4 mlb at 25.17% (9.4 mlb), per the FY2025 MD&A pp.3, 14–15. PEA pounds are not mineral reserves.
Phoenix holds under half the attributable pounds but almost four-fifths of the value, because its pounds come first, at about half Gryphon’s cash cost, and with a licence.
2.3 Phoenix (Wheeler River)
Table 3. Wheeler River study parameters (100% basis)
| Parameter | Phoenix (ISR) | Gryphon (underground) |
|---|---|---|
| Study | 2023 feasibility study; capital updated January 2026 | 2023 pre-feasibility cost update |
| Reserve | 56.7 mlb Proven & Probable at 11.7% (219,000 t) | 49.7 mlb Probable at 1.8% (1,257,000 t) |
| Production | 41.9 mlb in years 1–5 (8.4 mlb/yr); 14.8 mlb in years 6–10 (3.0 mlb/yr) | 7.6 mlb/yr |
| Mine life | 10 years | 6.5 years |
| Initial capital | CA$600.0m post-FID, 2026 dollars (2023 study: CA$419.4m) | CA$737.4m, Q3 2022 dollars |
| Sustaining capital | CA$234.1m | CA$98.7m |
| Cash operating cost | CA$8.51 (US$6.28) per lb | CA$17.27 (US$12.75) per lb |
| All-in cost | CA$24.92 (US$18.41) per lb | CA$34.50 (US$25.47) per lb |
| NPV 8%, after tax | CA$1.57bn adjusted case (credits opening tax balances; 2023 basic case CA$1.43bn), IRR 73% (UxC Q4 2025 midpoint US$68.89–78.36/lb) | CA$864.2m |
| NPV 8%, pre-tax | CA$2.34bn, IRR 105.9% (2023 study) | CA$1.43bn, IRR 41.4% |
Source: Denison FY2025 MD&A pp.14–15 and Q2 2026 MD&A p.8; Wheeler River NI 43-101 technical report, effective 23 June 2023, on SEDAR+, Sections 21–22. Study estimates, not achieved results; the Gryphon figures predate the 2026 capital update.
Phoenix lies on the Wheeler River property in the eastern Athabasca Basin. It is held through the Wheeler River Joint Venture — Denison 90% and operator, JCU (Canada) Exploration 10% — and Denison owns half of JCU, for a 95% effective interest. Saskatchewan’s royalties sit inside the study’s after-tax case; the filings used show no stream or prepayment on Phoenix.
The reserve is 3.4 mlb Proven at 24.5% and 53.3 mlb Probable at 11.4%, under NI 43-101 and effective 23 June 2023, at an 80.6% mine recovery and 99% process recovery; Measured and Indicated resources of 70.5 mlb include it. The approvals in hand run in sequence: Saskatchewan’s environmental assessment approval in July 2025, the Canadian Nuclear Safety Commission’s approval and its Licence to Prepare Site and Construct a Mine and Mill in February 2026, and the final investment decision on 24 February 2026. Approvals still to come are not itemised in the source set.
The January 2026 estimate put post-FID capital at CA$600.0 million, 43% above the 2023 study and excluding about CA$100 million spent before the decision. Property additions were CA$40.8 million in the first half of 2026 and the joint venture had CA$229.0 million of construction commitments; Section 7 carries CA$559.2 million still to spend. By the end of July more than 20% of site civil work was complete and the Phase 1 freeze wall had started. First production is targeted for mid-2028, at 8.4 mlb a year for five years and 3.0 mlb a year for five more.
The asset’s one risk is containment: the design depends on the freeze wall holding the mining solution inside the orebody, and Phase 1 is only now being installed.
2.4 Gryphon (Wheeler River)
Gryphon is a conventional underground deposit on the same property, at the same 95% interest. The 2023 cost update (Table 3) plans 7.6 mlb a year for 6.5 years from 49.7 mlb of Probable reserves at 1.8%, plus 1.9 mlb Inferred, for CA$737.4 million of initial capital in Q3 2022 dollars and an after-tax NPV of CA$864.2 million. It is unpermitted, unfunded and unscheduled; Section 7 carries it at 0.40× from after Phoenix’s fifth year, an assumption since the filings give no date. Its one risk is capital: the estimate predates the escalation that lifted Phoenix’s budget by 43%.
2.5 Other interests
The rest of the portfolio carries 5.3% of enterprise NAV. Denison holds 22.5% of the Orano-operated McClean Lake joint venture, one of the Athabasca’s mills, whose SABRE mining delivered Denison 145,926 lb in 2025 at about CA$36/lb; its toll-milling revenue is partly streamed to Ecora, a CA$31.5 million deferred-revenue balance. It holds 25.17% of the Orano-operated Midwest joint venture, whose 2025 preliminary economic assessment for Midwest Main ISR shows a CA$965 million after-tax NPV, an 82.7% IRR and CA$254 million of capital on a 100% basis, carried at 0.25×. Waterbury Lake (70.55%) carries no value. Exploration is increasingly partner-funded: Foremost vested 51% of ten projects in July 2026, and Cosa acquired 70% of Murphy Lake in January 2025.
2.6 Production, reserves & costs
Today Denison produces only its SABRE share. Phoenix would lift attributable output to about 8.0 mlb a year in its first five years, against a life average of 5.67 mlb on a 100% basis. Gryphon’s tonnage is six times Phoenix’s at a sixth of the grade, which is why its cash cost is twice as high.
Table 4. Reserves and resources by deposit (100%, NI 43-101)
| Deposit | Category | Tonnes (kt) | Grade (% U₃O₈) | Contained (mlb U₃O₈) |
|---|---|---|---|---|
| Phoenix | Proven | 6.3 | 24.5 | 3.4 |
| Phoenix | Probable | 212.7 | 11.4 | 53.3 |
| Phoenix | Measured & Indicated (incl. reserves) | 280.2 | 11.4 | 70.5 |
| Phoenix | Inferred | 5.6 | 2.6 | 0.3 |
| Gryphon | Probable | 1,257 | 1.8 | 49.7 |
| Gryphon | Inferred | 73 | 1.2 | 1.9 |
Source: Wheeler River NI 43-101 technical report, effective 23 June 2023, Sections 1, 14 and 15, on SEDAR+; Gryphon reserve per the FY2025 MD&A p.15. Resources include reserves; Inferred resources are not in the valuation.
Figure 4. Reserves by deposit and category
Figure data: Table 4.
2.7 Peer positioning
The peer set for every star in Section 9 is three Canadian-listed uranium companies with Athabasca Basin assets: Cameco (TSX/NYSE: CCJ), NexGen Energy (TSX/NYSE: NXE) and Paladin Energy (ASX/TSX: PDN); none is in a pending deal. Each is compared on quality metrics from its latest annual filing on hand.
Table 5. Peer quality metrics
| Company | Listing | Stage | Reserves (mlb U₃O₈) | Production (mlb) | Unit cost (US$/lb) |
|---|---|---|---|---|---|
| Cameco | TSX: CCJ / NYSE: CCJ | Producer | ~433 Proven & Probable (company share) | n/d | n/d |
| NexGen Energy | TSX: NXE / NYSE: NXE | Developer (Rook I) | 240 Probable | n/d | n/d |
| Paladin Energy | ASX: PDN / TSX: PDN | Producer (Langer Heinrich) | n/d | 4.82 (FY2026) | 43.3 cost of production (FY2026) |
| Denison Mines | TSX: DML / NYSE American: DNN | Developer (Phoenix) | 106.4 Proven & Probable (100%) | first production mid-2028 | 18.41 all-in (study) |
Source: Cameco 2025 Annual Information Form p.10; NexGen 2025 Annual Information Form on SEDAR+; Paladin FY2026 MD&A pp.4, 6; Denison per Tables 3 and 4. n/d: not in the peer filing on hand.
Denison has the smallest reserve of the three that file one but the highest grade, and on study figures the lowest cost: its all-in US$18.41/lb is under half Paladin’s achieved cost of production. Against Cameco and NexGen it is a shorter-lived, single-mine business.
3. Financials & balance sheet
Denison has no material revenue yet: CA$4.9 million in 2025, from its McClean Lake share and services. Net income swings on non-cash items — a CA$90.4 million profit in 2023, then losses of CA$91.1 million in 2024 and CA$217.3 million in 2025, and a first-half 2026 loss of CA$89.3 million despite a CA$25.6 million second-quarter profit — while operating cash flow has been negative every year, CA$68.1 million out in 2025. The cash line is the one to read. Capital spending is all growth: CA$50.5 million of property additions in 2025, rising with Phoenix construction; the filings give no sustaining and growth split. The terms used here are defined in the Financial Metrics guide.
Table 6. Five-year financial summary (CA$m unless stated)
| Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 20.0 | 9.01 | 1.9 | 4.0 | 4.9 |
| Revenue, YoY % | — | −55%1 | −79% | +117% | +22% |
| Cash margin | n/m | n/m | n/m | n/m | n/m |
| Net income (loss) | 19.0 | 14.4 | 90.4 | (91.1) | (217.3) |
| Diluted EPS (CA$) | 0.02 | 0.02 | 0.10 | (0.10) | (0.24) |
| Operating cash flow | (21.2) | (28.1) | (30.7) | (40.4) | (68.1) |
| Capex (all growth) | (1.2) | (6.9) | (3.2) | (7.7) | (50.5) |
| Free cash flow | (22.5) | (35.0) | (33.9) | (48.1) | (118.6) |
| Cash, year-end | 64.0 | 50.9 | 131.1 | 108.5 | 465.9 |
| ND/EBITDA | n/m | n/m | n/m | n/m | n/m |
| Diluted shares, weighted (m) | 793.7 | 828.7 | 854.0 | 892.2 | 896.6 |
| Dividend per share (CA$) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Source: Denison annual financial statements for FY2022 (FY2021–FY2022 columns), FY2023 (FY2023, restated FY2022) and FY2025 (FY2024–FY2025): statements of income p.8, cash flows p.10, financial position p.7; dividends per the 2025 Annual Information Form. Free cash flow = operating cash flow + property additions. n/m: not meaningful — no production and negative EBITDA.
Notes to Table 6
- FY2022 revenue as restated in the FY2023 statements, after services moved to discontinued operations (first reported CA$16.9m); FY2021 is not restated, so the FY2022 change mixes bases.
The cost deck. Phoenix’s study cash cost is CA$8.51/lb and its all-in cost CA$24.92/lb; the January 2026 update re-priced capital in 2026 dollars but kept the 2023 operating costs, so the cash cost carries three years of inflation risk. Saskatchewan royalties are price-linked and sit in the study’s after-tax case. Tax shelters the start: CA$411.0 million of unrecognised losses expire between 2026 and 2045, and the study’s Canadian development expense pool deducts 37.5% of additions made before 2028, 30% after.
Net cash and liquidity. At 30 June 2026 Denison held CA$465.3 million of cash against US$345 million of 4.25% convertible notes due 15 September 2031 (CA$475 million at face; carried at CA$687.3 million fair value) and CA$2.2 million of leases; Section 7 counts net cash of CA$462.2 million and the notes as shares, since their ~US$2.92 conversion price sits below the share price. A capped call, an asset of CA$56.8 million, offsets part of that dilution. Beside the cash sit CA$114.4 million of uranium investments at fair value, CA$18.0 million of equity holdings and CA$11.9 million of F3 Uranium debentures. The Bank of Nova Scotia facility provides CA$28.5 million of letters of credit (CA$4.5 million used), matures on 31 January 2027 and carries a tangible-net-worth covenant Denison meets; CA$36.8 million of surety bonds back reclamation obligations of CA$37.6 million. Net debt to EBITDA is not meaningful. The stress test is the funding gap: Phoenix’s CA$559.2 million remaining is covered with CA$20.8 million to spare at US$90/lb — a test of construction capital only, so corporate costs and SABRE net outflows to first production could still call for a top-up — and at US$60/lb the 950,000 lb would be worth CA$39.3 million less and the build would be CA$18.5 million short.
Table 7. 2026 outlook — forecast cash flows (CA$m)
| Line | 2026 outlook |
|---|---|
| Mineral sales (300,000 lb from SABRE) | 29.0 |
| Phoenix construction | (305.2) |
| Phoenix program | (15.2) |
| Exploration / evaluation | (17.3) / (13.5) |
| Development and operations (McClean Lake, Midwest, Elliot Lake) | (19.9) |
| Corporate administration and other | (31.9) |
| Net forecast cash outflow | (375.4) |
Source: Denison FY2025 MD&A, Outlook for 2026, p.38 (cash basis; Denison funds 100% of the Wheeler River joint venture’s spend). The lines shown sum to CA$374.0m; smaller items make up the balance.
Hedge book and sales. Denison runs no hedging program. It sold 750,000 lb in the second quarter of 2026 at CA$122.16 (US$89.17) per lb for CA$91.6 million, and has 600,000 lb committed for delivery from the third quarter of 2026 to the second quarter of 2027, of which 350,000 lb is fixed at US$95.17/lb (US$33.3 million). Long-term sales exceed 8 mlb firm, mostly after 2028 and market-related.
Capital returns and shares. Denison has never paid a dividend, and the facility restricts one. Shares outstanding were 905,216,127 on 12 August 2026, 920,225,396 fully diluted, plus 118,312,748 on conversion of the notes; the weighted diluted count rose 13% from 2021 to 2025.
4. Management, strategy & corporate structure
4.1 Management & governance
David Cates has been President and Chief Executive Officer since 2015 and a director since 2018. Elizabeth Sidle, with Denison since 2016, was promoted to Chief Financial Officer in December 2023. Jennifer Traub, a partner at the law firm Cassels Brock and a director since 2021, became Chair at the May 2024 annual meeting. The board has eight directors — Baik, Carson, Cates, Hartwick, Neuburger, Sterritt, Traub and Volker — of whom Jinsu Baik, since 2025, is the nominee of KHNP Canada, the Korea Hydro & Nuclear Power affiliate that holds a strategic relationship agreement with Denison, the one related party of note. Board independence and the committee list are in the management information circular, which is not in the source set. Directors and officers together own 3,006,882 shares, under 1%. The record is delivery: the approvals and the investment decision arrived in the sequence management set out.
4.2 Strategy
The frame is an ISR-led Athabasca pipeline: Phoenix to production by mid-2028, Gryphon on the same property next, then Midwest Main. Exploration is moved to partners’ budgets — Foremost’s earn-in and Cosa’s Murphy Lake stake — while Denison keeps the development assets. Marketing builds a contract book of more than 8 mlb firm and more than 15 mlb including advanced negotiations, mostly market-related, and the physical uranium bought earlier is sold to fund the build. The dated targets are CA$305.2 million of Phoenix construction spend in 2026 and first production in mid-2028.
4.3 Ownership & structure
The most material structure is the Wheeler River Joint Venture: Denison 90% and operator, JCU (Canada) Exploration 10%, with Denison owning half of JCU. Denison also holds 22.5% of McClean Lake and 25.17% of Midwest, both operated by Orano, and 70.55% of the Waterbury Lake Uranium Limited Partnership. Recent transactions run the other way, as partners earn in: Cosa acquired 70% of Murphy Lake in January 2025, and Foremost vested 51% of ten projects in July 2026. Obligations include the Ecora toll-milling stream, CA$3.5 million of flow-through spending still owed of CA$15.0 million raised, and the convertible notes. No holder of 5% or more is disclosed. The share count is 905,216,127 basic at 12 August 2026, with 5,122,830 options and 9,886,439 share units outstanding.
5. ESG & sustainability
Denison reported a 2025 total recordable injury rate of 2.58 per 200,000 hours, including contractors, with no lost-time injuries; earlier rates and emissions are not in its filings in the source set, so the dimension rests on less disclosure than a producer gives. In December 2025 it signed two Impact Benefit Agreements for Wheeler River — with Ya’thi Néné Land and Resource on behalf of three First Nations, and with the Métis parties. Its legacy liability is the Elliot Lake tailings area, closed in 1992, decommissioned by 1997 and now monitored.
6. Risks
Table 8. Risk register
| Risk | Type | Likelihood / impact (1–5) | Exposure | Mitigant |
|---|---|---|---|---|
| Freeze-wall containment and ISR performance | Operational | 3 / 5 | Phoenix is 76.5% of enterprise NAV | Phase 1 freeze wall under way; feasibility-level design |
| Phoenix capital overrun or delay | Balance sheet / dilution | 3 / 4 | CA$559.2m to spend against CA$462.2m net cash and CA$117.8m of uranium | the January 2026 re-estimate already absorbed a 43% rise |
| Uranium price | Commodity | 2 / 4 | fair value CA$1.73–4.40 across US$60–120/lb | 350,000 lb fixed at US$95.17/lb; physical inventory |
| Gryphon permitting and funding | Jurisdiction / permitting | 3 / 3 | 18.2% of enterprise NAV, unpermitted and unfunded | carried at 0.40× |
| Convertible dilution | Balance sheet / dilution | 4 / 2 | 118.3m conversion shares at ~US$2.92 | capped call, a CA$56.8m asset |
| Community consent | ESG | 2 / 3 | construction and operation of Wheeler River | two Impact Benefit Agreements, December 2025 |
| Partner dependence | Counterparty | 2 / 2 | Orano operates McClean Lake and Midwest | minority interests 5.3% of NAV |
Source: this analysis, from Sections 2–3 and 7; figures per Denison’s Q2 2026 and FY2025 filings. Ratings are the author’s assessment.
Figure 5. Risk matrix — likelihood against impact
Rare
Likely
Figure data: Table 8; each point prints likelihood × impact. Ratings are the author’s assessment, not disclosed figures.
Section 7 prices the top three: containment and execution in Phoenix’s 0.80× stage weight, capital in the funding line of the bridge, and price by running every grid price. The convertible’s dilution is already in the if-converted share count.
7. Valuation
Valuation as of 8 September 2026, in Canadian dollars. Horizon: spot fair value. Price deck: base uranium US$90/lb U₃O₈, the representative of the trailing averages of the month-end spot indicator — US$87.02 (3-month), US$85.97 (6-month) and US$84.75 (12-month) to 31 August 2026 — snapped to the fixed US$60–120/lb grid, with every grid price run as a scenario (deep bear US$60 / bear US$75 / base US$90 / bull US$105 / deep bull US$120). Discount rate 10% real, after-tax — the uranium single-asset rate, because Phoenix carries 76% of the enterprise net asset value — sensitised 8–12%. Share price CA$4.62 (TSX close, 8 September 2026); 1,038.5 m shares if-converted (920.2 m fully diluted plus 118.3 m on the Convertible Notes, whose US$2.92 conversion price sits below the share price); balance sheet at 30 June 2026; the US$ deck converts at US$1 = CA$1.3778 (8 September 2026).
Denison is valued as a developer: Phoenix, its flagship in-situ recovery mine, is licensed, funded and under construction for first production in mid-2028, and Gryphon, the second Wheeler River deposit, sits at pre-feasibility level. The method follows the How to Value Commodity Stocks guide. Each asset is built from its study rows and carries its stage risk in a row weight — 0.80× for Phoenix, 0.40× for Gryphon, 0.25× for the Midwest study — so the discount rate stays at the convention. The minority McClean Lake and Midwest interests, the 950,000 lb of physical uranium and the cash sit beside Phoenix in the bridge. The developer’s transaction-comparison and EV-per-reserve methods have no filed deal and no uranium anchor to stand on, so the second weighted method is a free-cash-flow yield on Phoenix’s first full year, discounted back to today. The scorecard’s driver line from Section 9, +0.10, moves both targets off their anchors: P/NAV from 1.00× to 1.10×, and the FCF yield from 7% to 6.4%.
Table 9. Load-bearing inputs — the figures the valuation turns on (full source register: Table 23)
| Input | Value | Where §7 uses it | Source |
|---|---|---|---|
| Wheeler River — Denison effective interest | 95.0% | Table 12, blocks 1, 2, 5 | Filed | Q2 2026 interim FS | Note 1 | “effective 95.0%" | p.5 |
| Phoenix Proven & Probable reserve (100%) | 56.7 Mlb U₃O₈ | Tables 12, 15 — life-average rate | Filed | FY2025 MD&A | Phoenix parameters table | “Proven & Probable reserves” | p.14 |
| Phoenix production, first five years / years six to ten (100%) | 41.9 Mlb / 14.8 Mlb | Table 12, block 1 | Filed | AIF 2024 | Phoenix parameters table | “First 5 years of reserves” | p.11 |
| Phoenix average cash operating cost | CA$8.51/lb | Tables 12, 15 | Filed | FY2025 MD&A | Phoenix parameters table | “Average cash operating costs” | p.14 |
| Phoenix post-FID initial capital (2026 dollars) | CA$600.0M | Table 12, block 1; Table 19 field 10 | Filed | Q2 2026 MD&A | Initial capital cost comparison | “Initial Capital” | p.8 |
| Phoenix 2023 FS NPV 8%, pre-tax / basic after-tax (100%) | CA$2.34B / CA$1.43B | Table 12 — after-tax factor | Filed | Wheeler River TR 2023 | Section 22.4.1 — Phoenix base case economic analysis (l.13422) | “basic after-tax NPV of $1.43 billion at an 8.0% discount rate, an IRR of 82.3%" | p.1 |
| Phoenix first production target | mid-2028 | Table 12 — discount to first production | Filed | FID release 24 Feb 2026 | CEO comment | “production from Phoenix by mid-2028” | p.1 |
| Gryphon production and life (100%) | 7.6 Mlb/yr for 6.5 years | Table 12, block 2 | Filed | FY2025 MD&A | Gryphon parameters table | “Average annual production” | p.15 |
| Gryphon initial capital | CA$737.4M | Table 12, block 2 | Filed | FY2025 MD&A | Gryphon parameters table | “Initial capital costs (2)" | p.15 |
| Cash and cash equivalents | CA$465,289k | Table 13 — net cash | Filed | Q2 2026 interim FS | Statement of financial position | “equivalents (note 4)" | p.1 |
| Physical uranium held | 950,000 lb | Table 13 — investments at the deck | Filed | Q2 2026 MD&A | Commercial activities | “physical uranium and 145,926 pounds U” | p.24 |
| Reclamation obligations, current / non-current | CA$1,085k / CA$36,538k | Table 13 | Filed | Q2 2026 interim FS | Statement of financial position | “obligations (note 11)" | p.1 |
| Shares, fully diluted incl. conversion shares | 1,038,538,144 | Table 13 — per share | Derived | 920,225,396 fully diluted (Q2 2026 MD&A p.26) + 118,312,748 conversion shares (note 12 p.13); capped call offsets part above US$2.92 |
| U₃O₈ spot, 3-, 6-, 12-month averages | US$87.02 · US$85.97 · US$84.75/lb | Figure 7, Table 18 — deck | Derived | Cameco industry average of UxC/TradeTech month-end spot: 85.00, 86.38, 89.68 (to 31 Aug 2026) |
Source: each row’s filing as cited — Denison’s Q2 2026 and FY2025 filings and the Wheeler River technical report on SEDAR+; deck rows per Cameco’s uranium price series.
8. Near-term catalysts (1–3 years)
Table 20. Catalysts
| Catalyst | Timing (guidance) | Why it matters |
|---|---|---|
| Phase 1 freeze wall and Phoenix site works | 2026–2027 | first test of the containment the ISR design depends on |
| Phoenix construction spend of CA$305.2m | 2026 | budget tracking against the CA$600.0m estimate |
| Delivery of 600,000 lb, 350,000 lb at US$95.17/lb | Q3 2026–Q2 2027 | cash for the build at a fixed price above the base deck |
| Renewal of the letters-of-credit facility | by 31 Jan 2027 | backs the reclamation bonding |
| Long-term contracting beyond 8 mlb firm | 2026–2028 | volume and price certainty for Phoenix’s first years |
| Phoenix first production | mid-2028 | turns Denison from developer into producer |
Source: Denison Q2 2026 MD&A pp.2, 24–25; FY2025 MD&A p.38; FID release, 24 February 2026.
Each construction milestone retires part of Phoenix’s stage discount ahead of the mid-2028 start.
8.1 Takeover optionality
A licensed, funded, high-grade Saskatchewan mine due to produce in 2028 is the kind of asset larger producers and utilities buy, but the evidence for a bidder is thin. The only filed strategic link is KHNP Canada’s strategic relationship agreement and board seat; Orano is Denison’s operating partner at McClean Lake and Midwest but holds no filed interest in Wheeler River. The disqualifiers are price and structure: the shares stand at 2.09 times NAV, and 118.3 million conversion shares add to the equity any bidder must buy. No approach has been announced or reported, and the verdict in Section 9 carries no takeover value.
Table 21. Takeover case
| Factor | Evidence | Effect on a bid |
|---|---|---|
| Asset | Phoenix licensed, funded, first production mid-2028 | supports interest |
| Filed strategic link | KHNP Canada: strategic relationship agreement; board nominee since 2025 | the only sourced counterparty |
| Operating partner | Orano at McClean Lake (22.5%) and Midwest (25.17%) | adjacency; no filed interest in Wheeler River |
| Price | 2.09× NAV per share of CA$2.21 | raises the hurdle |
| Dilution | 118.3m conversion shares at ~US$2.92 | adds to the equity a bidder buys |
Source: Denison FY2025 MD&A p.36 (KHNP) and Q2 2026 interim statements note 1 (interests); price and NAV per Section 7.
9. Rating & verdict
Denison is scored as a uranium developer against the three peers in Section 2.7 — Cameco, NexGen Energy and Paladin Energy — in whole stars. Developer weights put balance sheet, management, asset quality and reserves at 15% each, and cost, growth, capital allocation, jurisdiction and ESG at 8% each. Cost is scored on the Phoenix feasibility study and labelled as an estimate.
Figure 9. Scorecard by dimension, 8 September 2026
Figure data: Table 22. Each spoke prints its stars and weight; the dashed ring is the weighted composite, 3.70/5.
Table 22. Scorecard rationale
| Dimension | Weight | Stars | Rationale |
|---|---|---|---|
| 5. Balance sheet & liquidity | 15% | ★★★★ | Remaining Phoenix capital of CA$559.2m against CA$462.2m net cash and CA$117.8m of physical uranium — construction capital covered with CA$20.8m to spare, corporate and SABRE outflows to first production outside the test; US$345m of notes due 2031 — above the peer median for a developer (Section 3) |
| 7. Management & governance | 15% | ★★★★ | CEO David Cates, in post since 2015, delivered the provincial approval (July 2025), the federal licence and the investment decision (February 2026) in sequence; insiders under 1% and board independence not in the source set — above the peer median (Section 4.1) |
| 1. Asset quality & scale | 15% | ★★★★ | Phoenix’s 56.7 mlb at 11.7% U₃O₈, 8.4 mlb a year for five years — a higher grade than any peer reserve here, a smaller one than NexGen’s 240 mlb; one orebody carries 76.5% of NAV (Tables 2, 5) |
| 3. Reserves, life & replacement | 15% | ★★ | 103.0 mlb Probable plus 3.4 mlb Proven, below Cameco (~433 mlb) and NexGen (240 mlb); Phoenix’s life is ten years and Gryphon’s 6.5 years is unpermitted (Table 4) |
| 2. Cost position & margins | 8% | ★★★★★ | Study cash cost US$6.28/lb and all-in US$18.41/lb against Paladin’s achieved US$43.3/lb; a 79.5% margin at US$90/lb — a feasibility-study estimate, not an achieved result (Table 3) |
| 4. Growth & optionality | 8% | ★★★★ | From 145,926 lb (2025 SABRE share) to about 8 mlb a year at Phoenix, above Paladin’s 4.82 mlb, with Gryphon’s 7.6 mlb a year and the Midwest PEA behind it (Tables 2, 3) |
| 6. Capital allocation & returns | 8% | ★★★ | No dividend; the build financed with notes and 750,000 lb of uranium sold at CA$122.16/lb rather than new equity; weighted diluted shares up 13% over 2021–2025 — the peer median (Section 3) |
| 8. Jurisdiction & geopolitics | 8% | ★★★★★ | Every asset in Saskatchewan, the Athabasca jurisdiction Cameco and NexGen share, with provincial and federal approvals in hand for Phoenix; Paladin adds Namibia — top of the peer set (Section 2.3) |
| 9. ESG & licence to operate | 8% | ★★★ | 2025 recordable injury rate 2.58 with no lost-time injuries and two Impact Benefit Agreements (December 2025); emissions and prior-year safety not in the source set — the peer median (Section 5) |
| Composite | 100% | ★★★½ | Solid |
Source: this analysis, Sections 2–6, and the peer filings cited under Table 5 (Cameco, Paladin, NexGen and Denison).
Σ(weight × stars) = 0.15 × (4 + 4 + 4 + 2) + 0.08 × (5 + 4 + 3 + 5 + 3) = 2.10 + 1.60 = 3.70/5, which rounds to ★★★½, Solid.
What would move the stars. Reserves are the weakest star and the easiest to lift: a permitted, re-costed Gryphon would add a second mine life. Cost would lose its fifth star if Phoenix’s first years run well above the study’s US$6.28/lb, and the balance sheet would lose one if an overrun forced a raise.
The two-axis verdict. As of 8 September 2026, Denison rates ★★★½ Solid with a read of Overvalued (wide band) — the verdict is Full: at CA$4.62 the blended fair value of CA$3.17 implies −31.4%, and the market-implied uranium deck of ~US$125/lb sits well above the US$84.75/lb twelve-month average. The target multiples — P/NAV 1.10× and FCF yield 6.4% — carry a +10% driver line from cost and jurisdiction (+4% each) and asset quality and balance sheet (+2% each), less 2% for reserves. The bull case needs Phoenix delivered on budget by mid-2028 and uranium above ~US$92/lb, where the read turns Modestly overvalued; the bear case is a containment or cost setback, and no grid price moves the read lower. The freeze wall tips it. To rank Denison against every listed uranium name on the same dimensions, screen the sector on Metal Pilot’s uranium mining stock screener.
10. Sources, methodology & disclaimer
10.1 Sources, methodology & data vintage
Company filings. Denison’s Q2 2026 condensed interim statements and MD&A (filed 12 August 2026), the Q1 2026 statements, the FY2025 annual statements and MD&A, the 2025 and 2024 Annual Information Forms, the FY2022 and FY2023 statements, and the 2026 releases on the capital update (2 January), the CNSC licence (19 February) and the investment decision (24 February); the Wheeler River NI 43-101 technical report (effective 23 June 2023) and the Midwest PEA technical report on SEDAR+.
Market and peer data. Share price CA$4.62 and USD/CAD 1.3778 at the 8 September 2026 close per Yahoo Finance; uranium month-end prices from Cameco’s UxC/TradeTech series to 31 August 2026. Peers from Cameco’s and NexGen’s 2025 Annual Information Forms and Paladin’s FY2026 MD&A.
Methodology. Data as of 8 September 2026; balance sheet at 30 June 2026; reserves effective 23 June 2023. Base deck uranium US$90/lb on the fixed US$60–120/lb grid (US$60, 75, 90, 105 and 120), 10% real after tax, sensitised 8–12%; methods weighted risked P/NAV 55% and FCF-yield support 45%; scorecard on developer weights against three peers. Refreshed on each annual report and on material events.
Re-run log. 10 October 2026: model rebuilt and the scorecard stars handed to the driver line — at CA$4.62 the fair value is CA$3.42, implied −26.0%, Modestly overvalued (wide band), from CA$3.12 and Overvalued (wide band) before the stars; quality rating 3.7/5 Solid, from 4.3/5 High quality. 10 October 2026 (pre-launch fixes): Phoenix’s after-tax factor moved to the 2023 study’s basic case (CA$1.43bn ÷ CA$2.34bn, as Gryphon) and Midwest rolled to the valuation date — NAV/share CA$2.34 → CA$2.21, fair value CA$3.42 → CA$3.17, implied −26.0% → −31.4%, read Modestly overvalued → Overvalued (wide band). The model’s full output is claude/valuation-models/denison-mines-dml.out.md. Omitted figures. The asset location map is not built; Figures 2 and 3 show value and planned pounds by asset in place of the revenue split, because Denison is pre-revenue.
Data gaps and the documents that close them. Board independence, committees and holders of 5% or more (the 2026 management information circular); prior-year safety and emissions (the sustainability report); analyst consensus (an archived capture at the as-of date); Denison’s own P/NAV history (a provider series); Gryphon’s timing and current capital (a Gryphon study update); the uranium five-year average (Cameco’s price history).
The load-bearing inputs open Section 7 as Table 9; every figure’s full provenance is in the register below.
Provenance: Denison Mines Corp. — Annual Information Form — 2025.
Table 23. Full source register for the valuation
| Input | Value | As of | Where §7 uses it | Source |
|---|---|---|---|---|
| Condensed interim FS, 30 June 2026 | ||||
| Wheeler River — Denison effective interest (WRJV 90% + half of JCU's 10%; operator) | 95.0% | 30 Jun 2026 | NAV — attributable share | Filed | Q2 2026 interim FS | Note 1 | "effective 95.0%" | p.5 |
| Midwest JV — Denison interest (Orano-operated) | 25.17% | 30 Jun 2026 | NAV — Midwest | Filed | Q2 2026 interim FS | Note 1 | "25.17% interest in the Midwest Joint" | p.5 |
| Phoenix / PP&E additions, six months to 30 Jun 2026 (cash flow) | $40,812k (H1 2025: $11,319k) | 30 Jun 2026 | Remaining capital — spent to date | Filed | Q2 2026 interim FS | Statement of cash flows | "property, plant and equipment (note 8)" | p.4 |
| CLJV toll-milling stream with Ecora — deferred revenue balance | $31,502k | 30 Jun 2026 | Encumbrance — MLJV toll milling | Filed | Q2 2026 interim FS | Note 10 | "Milling-Ecora" | p.11 |
| Cash and cash equivalents | $465,289k | 30 Jun 2026 | Net cash; liquidity | Filed | Q2 2026 interim FS | Statement of financial position | "equivalents (note 4)" | p.1 |
| Trade and other receivables | $7,376k | 30 Jun 2026 | Working capital | Filed | Q2 2026 interim FS | Statement of financial position | "receivables" | p.1 |
| Inventories (current) / ore in stockpiles (non-current) | $16,456k / $2,098k | 30 Jun 2026 | Working capital | Filed | Q2 2026 interim FS | Statement of financial position | "Inventories (note" | p.1 |
| Investments — uranium, current / non-current (fair value) | $72,274k / $42,160k | 30 Jun 2026 | NAV — physical uranium | Filed | Q2 2026 interim FS | Statement of financial position | "Investments-uranium" | p.1 |
| Investments — equity instruments, current / non-current | $12,097k / $5,918k | 30 Jun 2026 | NAV — investments | Filed | Q2 2026 interim FS | Statement of financial position | "Investments-equity" | p.1 |
| Investments — debt instruments (F3 debentures) | $11,923k | 30 Jun 2026 | NAV — investments | Filed | Q2 2026 interim FS | Statement of financial position | "Investments-debt" | p.1 |
| Investments — joint venture (JCU) | $19,457k | 30 Jun 2026 | NAV — investments | Filed | Q2 2026 interim FS | Statement of financial position | "venture (note 7)" | p.1 |
| Capped Call derivative options (asset) | $56,754k | 30 Jun 2026 | Derivatives | Filed | Q2 2026 interim FS | Statement of financial position | "derivative options (note 12)" | p.1 |
| Restricted cash and investments | $11,198k | 30 Jun 2026 | Net cash (excluded) | Filed | Q2 2026 interim FS | Statement of financial position | "Restricted cash" | p.1 |
| Accounts payable and accrued liabilities | $55,313k | 30 Jun 2026 | Working capital | Filed | Q2 2026 interim FS | Statement of financial position | "accrued liabilities (note 9)" | p.1 |
| Deferred revenue, current / non-current (Ecora toll-milling stream) | $4,500k / $36,051k | 30 Jun 2026 | Liabilities — non-cash | Filed | Q2 2026 interim FS | Statement of financial position | "(note 10)" | p.1 |
| Reclamation obligations, current / non-current | $1,085k / $36,538k | 30 Jun 2026 | Net cash — closure | Filed | Q2 2026 interim FS | Statement of financial position | "obligations (note 11)" | p.1 |
| Convertible Notes (carrying value; US$345M face) | $687,272k | 30 Jun 2026 | Net debt | Filed | Q2 2026 interim FS | Statement of financial position | "Convertible Notes" | p.1 |
| Other liabilities, current / non-current (incl. leases) | $577k / $2,540k | 30 Jun 2026 | Net debt — leases | Filed | Q2 2026 interim FS | Statement of financial position | "liabilities" | p.1 |
| Convertible Notes — conversion rate and price | 342.9355 shares per US$1,000 · ≈US$2.92/share | 30 Jun 2026 | Dilution — conversion shares | Filed | Q2 2026 interim FS | Note 12 | "The conversion rate is 342.9355 common shares" | p.13 |
| Convertible Notes — shares on full conversion | 118,312,748 | Dilution | Derived | US$345,000,000 / 1,000 × 342.9355 (Q2 2026 interim FS note 12 p.13) | |
| Press releases, 2026 | ||||
| Phoenix — first production target (≈2-year build) | mid-2028 | 24 Feb 2026 | Ramp — start year | Filed | FID release 24 Feb 2026 | CEO comment | "production from Phoenix by mid-2028" | p.1 |
| MD&A, year ended 31 December 2025 | ||||
| Phoenix Proven & Probable reserve (100%, NI 43-101, 0.5% cut-off, ISR recoverable) | 56.7 Mlb U3O8 (219,000 t at 11.7% U3O8) | 23 Jun 2023 | Phoenix block — reserve | Filed | FY2025 MD&A | Phoenix parameters table | "Proven & Probable reserves" | p.14 |
| Phoenix mine life | 10 years | 30 Jun 2026 | Phoenix block — life | Filed | FY2025 MD&A | Phoenix parameters table | "Mine life" | p.14 |
| Phoenix average cash operating cost | $8.51 (US$6.28) per lb U3O8 | 30 Jun 2026 | Phoenix block — unit cost | Filed | FY2025 MD&A | Phoenix parameters table | "Average cash operating costs" | p.14 |
| Phoenix all-in cost (pre-tax; opex + post-FID capital + closure) | $24.92 (US$18.41) per lb U3O8 | 30 Jun 2026 | Phoenix block — unit cost | Filed | FY2025 MD&A | Phoenix parameters table | "All-in cost" | p.14 |
| Gryphon Probable reserve (100%, conventional underground) | 49.7 Mlb U3O8 (1,257,000 t at 1.8% U3O8) | 23 Jun 2023 | Gryphon block — reserve | Filed | FY2025 MD&A | Gryphon parameters table | "Probable reserves (1)" | p.15 |
| Gryphon mine life and average production (100%) | 6.5 years · 7.6 Mlb U3O8/yr | 30 Jun 2026 | Gryphon block — annuity | Filed | FY2025 MD&A | Gryphon parameters table | "Average annual production" | p.15 |
| Gryphon initial capital (Q3 2022 dollars; excludes $56.5M pre-FID) | $737.4M | 30 Jun 2026 | Gryphon block — capital | Filed | FY2025 MD&A | Gryphon parameters table | "Initial capital costs (2)" | p.15 |
| Gryphon average cash operating cost and all-in cost | $17.27 (US$12.75) · AIC $34.50 (US$25.47) per lb | 30 Jun 2026 | Gryphon block — unit cost | Filed | FY2025 MD&A | Gryphon parameters table | "Average cash operating costs" | p.15 |
| Midwest Main ISR PEA (100%): after-tax NPV, IRR, initial capital | $965M · IRR 82.7% · capex $254M | 31 Dec 2025 | Midwest block (25.17%) | Filed | FY2025 MD&A | 2025 highlights | "after-tax base-case NPV of $965 million" | p.3 |
| 2026 Outlook — corporate administration & other | $(31,944)k | 31 Dec 2025 | Corporate cost | Filed | FY2025 MD&A | Outlook for 2026 | "Corporate Administration & Other" | p.38 |
| NI 43-101 Wheeler River technical report, effective 23 June 2023 | ||||
| Phoenix Measured & Indicated resource (100%, inclusive of reserves, 0.1% cut-off) | 280.2 kt at 11.4% for 70.5 Mlb U3O8 | 23 Jun 2023 | Phoenix block — resource | Filed | Wheeler River TR 2023 | Section 14 — Phoenix mineral resource table, tonnes column (l.7326; 111.3 is the volume in k m³) | "Total Measured and Indicated" | p.1 |
| Phoenix 2023 FS basic after-tax NPV 8% and IRR (100%; no opening tax balances credited) | $1.43B · IRR 82.3% | 23 Jun 2023 | Phoenix block — after-tax factor | Filed | Wheeler River TR 2023 | Section 22.4.1 — Phoenix base case economic analysis (l.13422) | "basic after-tax NPV of $1.43 billion at an 8.0% discount rate, an IRR of 82.3%" | p.1 |
| Phoenix 2023 FS base-case pre-tax NPV 8% (100%) and IRR | $2.34B · IRR 105.9% | 23 Jun 2023 | Phoenix block — pre-tax cross-check | Filed | Wheeler River TR 2023 | Section 22 — economic analysis (l.13421) | "pre-tax NPV of $2.34 billion at an 8.0% discount rate, an IRR of 105.9%" | p.1 |
| Gryphon 2023 PFS cost update — pre-tax NPV 8% (100%) and IRR | $1.43B · IRR 41.4% | 23 Jun 2023 | Gryphon block — study NPV | Filed | Wheeler River TR 2023 | Section 22 — Gryphon economic analysis (l.13748) | "pre-tax NPV of $1.43 billion at an 8.0% discount rate, an IRR of 41.4%" | p.1 |
| Gryphon 2023 PFS cost update — after-tax NPV 8% (100%; no adjusted case) | $864.2M | 23 Jun 2023 | Gryphon block — study NPV | Filed | Wheeler River TR 2023 | Section 1 — Gryphon summary (l.2219) | "The results show an after-tax NPV of $864.2 million" | p.1 |
| Gryphon sustaining capital | $98.7M | 23 Jun 2023 | Gryphon block — sustaining | Filed | Wheeler River TR 2023 | Section 21 — Gryphon capital costs (l.12819) | "The total sustaining capital is estimated at $98.7 million" | p.1 |
| Phoenix sustaining capital (2023 FS) | $234.1M | 23 Jun 2023 | Phoenix block — sustaining | Filed | Wheeler River TR 2023 | Section 21 — Phoenix capital costs (l.12453) | "The total sustaining capital is estimated at $234.1 million" | p.1 |
| Annual Information Form, year ended 31 December 2024 | ||||
| Phoenix production profile (100%) — not printed in this form in the TR; cited to the paginated 2024 AIF (same figures as the 2025 AIF) | first 5 years 41.9 Mlb (avg 8.4 Mlb/yr); remaining 14.8 Mlb (avg 3.0 Mlb/yr) | 31 Dec 2024 | Phoenix block — annuity | Filed | AIF 2024 | Phoenix parameters table | "First 5 years of reserves" | p.11 |
| MD&A, six months ended 30 June 2026 | ||||
| Phoenix post-FID initial capital (Class 2, 2026 dollars; excludes ~$100M pre-FID) | $600.0M (2023 FS: $419.4M) | 2 Jan 2026 | Phoenix block — remaining capital | Filed | Q2 2026 MD&A | Initial capital cost comparison | "Initial Capital" | p.8 |
| Phoenix post-tax NPV 8% (adjusted post-tax case, 100%) — updated capex vs 2023 FS | $1.57B (2023 FS: $1.56B) | 2 Jan 2026 | Phoenix block — study NPV | Filed | Q2 2026 MD&A | Initial capital cost comparison | "Post-Tax NPV 8% (5)" | p.8 |
| Phoenix study price basis (updated case) | UxC Composite Midpoint Q4 2025: US$68.89–78.36/lb | 2 Jan 2026 | Phoenix block — deck basis | Filed | Q2 2026 MD&A | Initial capital cost comparison | "Base Case Uranium Price" | p.8 |
| Physical uranium held + concentrate inventory, 30 Jun 2026 | 950,000 lb + 145,926 lb (≈1.1 Mlb) | 30 Jun 2026 | NAV — physical uranium | Filed | Q2 2026 MD&A | Commercial activities | "physical uranium and 145,926 pounds U" | p.24 |
| Committed deliveries Q3 2026–Q2 2027; fixed-price portion | 600,000 lb committed; 350,000 lb fixed at US$95.17/lb (US$33.3M) | 30 Jun 2026 | Cash — monetisation; hedge-like sales | Filed | Q2 2026 MD&A | Commercial activities | "US$95.17/lb U" | p.24 |
| Common shares issued and outstanding, 12 Aug 2026 | 905,216,127 | 12 Aug 2026 | Per-share — basic | Filed | Q2 2026 MD&A | Outstanding share data | "there were 905,216,127 common shares issued and outstanding" | p.26 |
| Common shares, fully diluted (options + share units; excludes convertible notes), 12 Aug 2026 | 920,225,396 | 12 Aug 2026 | Per-share — diluted | Filed | Q2 2026 MD&A | Outstanding share data | "common shares on a fully-diluted" | p.26 |
| Annual Information Form, year ended 31 December 2025 | ||||
| Phoenix reserve basis — mine recovery; process recovery | 80.6% mine · 99% process; US$50/lb, CA$/US$ 1.33 | 23 Jun 2023 | Phoenix block — basis | Filed | AIF 2025 | Phoenix reserve notes | "A mine recovery of 80.6%" |
| SABRE (McClean North) 2025 production — Denison share and cash cost | 145,926 lb U3O8 at ~$36/lb | 31 Dec 2025 | MLJV block | Filed | AIF 2025 | McClean Lake | "share: 145,926 pounds of U3O8" |
| NI 43-101 Midwest PEA technical report, effective 6 August 2025 | ||||
| Midwest Main PEA effective date | 6 August 2025 | 6 Aug 2025 | Midwest block — roll to the valuation date | Filed | Midwest PEA TR 2025 | Title page (l.14) | "Effective date: August 6, 2025" | p.1 |
| Market layer, as of 8 September 2026 | ||||
| DML close, TSX | CA$4.62 | 8 Sep 2026 | §1 statcard; per-share | Market | Yahoo Finance | "DML.TO daily close" | 8 Sep 2026 |
| USD/CAD | 1.3778 | 8 Sep 2026 | Currency bridge | Market | Yahoo Finance | "CAD=X daily close" | 8 Sep 2026 |
| Market capitalisation (basic, 905,216,127 shares) | CA$4,182M · US$3,035M | 8 Sep 2026 | §1 statcard | Derived | CA$4.62 × 905,216,127 (Q2 2026 MD&A p.26); ÷ USD/CAD 1.3778 |
| Shares, fully diluted incl. conversion shares | 1,038,538,144 | 8 Sep 2026 | Per-share — diluted | Derived | 920,225,396 fully diluted (Q2 2026 MD&A p.26) + 118,312,748 conversion shares (note 12 p.13); capped call offsets part above US$2.92 |
| U3O8 spot, 3-month trailing average (Jun–Aug 2026) | US$87.02/lb | 31 Aug 2026 | Deck | Derived | Cameco industry average of UxC/TradeTech month-end spot: 85.00, 86.38, 89.68 (to 31 Aug 2026) |
| U3O8 spot, 6-month trailing average (Mar–Aug 2026) | US$85.97/lb | 31 Aug 2026 | Deck | Derived | Cameco month-end spot Mar–Aug 2026: 84.25, 86.35, 84.18, 85.00, 86.38, 89.68 |
| U3O8 spot, 12-month trailing average (Sep 2025–Aug 2026) | US$84.75/lb | 31 Aug 2026 | Deck | Derived | Cameco month-end spot Sep 2025–Aug 2026, sum 1,017.05 / 12 |
Source: the facts file behind this analysis — the filed figures read back beside their quoted labels (sync_post, 10 Oct 2026), market and derived rows per their stated sources; filings via SEDAR+ and Denison’s investor pages.
10.2 Disclaimer & disclosure
This analysis is for information only and is not investment advice, a recommendation or an offer to buy or sell any security. Do your own research or consult a licensed adviser. It is a point-in-time snapshot as of 8 September 2026: the share price, market value and valuation read all move. Reserve, resource and study figures are estimates on the bases stated beside each table, not achieved results. Section 8.1 states possibilities, not expectations, and the verdict is an analytical read, never an instruction. This report was prepared with AI assistance; figures come from primary filings, but verify them against the original documents before acting. As of 18 November 2026, the author holds no position in the company this analysis covers.